Cytokine receptor signal transduction and the control of hematopoietic cell development

Annual Review of Cell and Developmental Biology

Volumn 12, Issue , 1996, Pages 91-128

  Watowich, Stephanie S ^a   Wu, Hong ^b,c   Socolovsky, Merav ^b,c   Klingmuller, Ursula ^b,c   Constantinescu, Stefan N ^b,c   Lodish, Harvey F ^b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

cytokine receptors; hematopoiesis; receptor associated diseases; signal transduction

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE RECEPTOR; HEMOPOIETIC GROWTH FACTOR; PHOSPHATASE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; VIRUS ENVELOPE PROTEIN;

CELL DIFFERENTIATION; COLONY FORMATION; COMBINED IMMUNODEFICIENCY; ERYTHROCYTOSIS; GENE EXPRESSION; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LARON SYNDROME; LEUKEMIA; MOLECULAR CLONING; NEUTROPENIA; NONHUMAN; PATHOGENESIS; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION;

EID: 0029769940     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.12.1.91     Document Type: Review

References (280)

1. Agarwal SK, Cogburn LA, Burnside J. 1994. Dysfunctional growth hormone receptor in a strain of sex-linked dwarf chicken: evidence for a mutation in the intracellular domain. J. Endocrinol. 142:427-34
2. Ahlers N, Hunt N, Just U, Laker C, Ostertag W, Nowock J. 1994. Selectable retrovirus vectors encoding Friend virus gp55 or erythropoietin induce polycythemia with different phenotypic expression and disease progression. J. Virol. 68:7235-43
3. Akira S, Nishio Y, Inoue M, Wang X-J, Wei S, et al. 1994. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77:63-71
4. Alexander WS, Metcalf D, Dunn AR. 1995. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J. 14:5569-78
5. Amselem S, Duquesnoy P, Attree O, Novelli G, Bousnina S, et al. 1989. Laron dwarfism and mutations of the growth hormone-receptor gene. N. Engl. J. Med. 321:989-95
6. Amselem S, Sobrier ML, Duquesnoy P, Rappaport R, Postel-Vinay MC, et al. 1991. Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism. J. Clin. Invest. 87:1098-102
7. Arai K-I, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. 1990. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:783-836
8. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, et al. 1993. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-44
9. Argetsinger LS, Hsu GW, Myers MG Jr, Billestrup N, White MF, Carter-Su C. 1995. Growth hormone, interferon-γ and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270:14685-92
10. Barber DL, DeMartino JC, Showers MO, D'Andrea AD. 1994. A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation. Mol. Cell. Biol. 14:2257-65
11. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, et al. 1994. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117-24
12. Bazan JF. 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87:6934-38
13. Bazan JF. 1995. Postmodern complexes. Nature 376:217-18
14. Ben-David Y, Bernstein A. 1991. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66:831-34
15. Berg MA, Argente J, Chernausek S, Gracia R, Guevara-Aguirre J, et al. 1993. Diverse growth hormone receptor gene mutations in Laron syndrome. Am. J. Hum. Genet. 52:998-1005
16. Bernad A, Kopf M, Kulbacki R, Weich N, Koehler G, Gutierrez-Ramos JC. 1994. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1:725-31
17. Boulton TG, Stahl N, Yancopoulos GD. 1994. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem. 269:11648-55
18. Boulton TG, Zhong Z, Wen Z, Darnell JE, Stahl N, Yancopoulos GD. 1995. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA 92:6915-19
19. Boutin JM, Jolicoeur C, Okamura H, Gagnon J, Edery M, et al. 1988. Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53:69-77
20. Campbell GS, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA, Carter-Su C. 1994. Activation of Jak2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc. Natl. Acad. Sci. USA 91:5232-36
21. Choi ES, Hokom M, Bartley T, Li YS, Ohashi H, et al. 1995. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. Stem Cells 13:317-22
22. Chung SW, Wolff L, Ruscetti SK. 1989. Transmembrane domain of the envelope gene of a polycythemia-inducing retrovirus determines erythropoietin-independent growth. Proc. Natl. Acad. Sci. USA 86:7957-60
23. Corey SJ, Burkhardt AL, Bolen JB, Geahlem RL, Tkatch LS, Tweardy DJ. 1994. Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with lyn and syk protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA 91:4683-87
24. Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, et al. 1990. A new cytokine receptor superfamily. Trends Biochem. Sci. 15:265-70
25. Counts DR, Cutler G Jr. 1995. Growth hormone insensitivity syndrome due to point deletion and frame shift in the growth hormone receptor. J. Clin. Endocrinol. Metab. 80:1978-81
26. Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA. 1991. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-25
27. Dale TC, Imam AM, Kerr IM, Stark GR. 1989. Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells. Proc. Natl. Acad. Sci. USA 86:1203-7
28. Damen JE, Cutler RL, Jiao H, Yi T, Krystal G. 1995b. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. J. Biol. Chem. 270:23402-8
29. Damen JE, Wakao H, Miyajima A, Krosl J, Humphries RK, et al. 1995a. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14:5557-68
30. D'Andrea AD, Fasman GD, Lodish HF. 1989a. Erythropoietin receptor and interleukin-2 receptor β chain: a new receptor family. Cell 58:1023-24
31. D'Andrea AD, Lodish HF, Wong GG. 1989b. Expression cloning of the murine erythropoietin receptor. Cell 57:277-85
32. D'Andrea AD, Yoshimura A, Youssoufian H, Zon LI, Koo JW, Lodish HF. 1991. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol. Cell. Biol. 11:1980-87
33. DaSilva L, Howard OMZ, Rui H, Kirken RA, Farrar WL. 1994. Growth signaling and Jak2 association mediated by membrane-proximal cytoplasmic regions of the prolactin receptor. J. Biol. Chem. 269:18267-70
34. David M, Petricoin E III, Benjamin C, Pine R, Weber MJ, Lamer AC. 1995. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins. Science 269:1721-23
35. Davis JA, Linzer DIH. 1989. Expression of multiple forms of the prolactin receptor in mouse liver. Mol. Endocrinol. 3:674-80
36. Davis S, Aldrich TH, Ip NY, Stahl N, Scherer S, et al. 1993a. Released form of CNTF receptor or component as a soluble mediator of CNTF responses. Science 259:1736-39
37. Davis S, Aldrich TH, Stahl N, Pan L, Taga T, et al. 1993b. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 260:1805-8
38. Davis S, Aldrich TH, Valenzuela DM, Wong V, Furth ME, et al. 1991. The receptor for ciliary neurotrophic factor. Science 253:59-63
39. DeChiara TM, Vejsada R, Poueymirou WT, Acheson A, Suri C, et al. 1995. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 83:313-22
40. Decker T, Lew DJ, Mirkovitch J, Darnell JE. 1991. Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor. EMBO J. 10:927-32
41. de la Chapelle A, Sistonen P, Lehvaslaiho H, Ikkala E, Juvonen E. 1993a. Familial erythrocytosis genetically linked to erythropoietin receptor gene. Lancet 341:82-84
42. de la Chapelle A, Traskelin A-L, Juvonen E. 1993b. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc. Natl. Acad. Sci. USA 90:4495-99
43. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, et al. 1994. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533-38
44. De Vos AM, Ultsch M, Kossiakoff AA. 1992. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-11
45. Devos R, Plaetinck G, Van der Heyden J, Cornelis S, Vandekerckhove J, et al. 1991. Molecular basis of a high affinity murine interleukin-5 receptor. EMBO J. 10:2133-37
46. Dexter TM, Spooncer E. 1987. Growth and differentiation in the hemopoietic system. Annu. Rev. Cell Biol. 3:423-41
47. DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ. Proc. Natl. Acad. Sci. USA 92:377-81
48. Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP. 1995. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N. Engl. J. Med. 333:487-93
49. Dong F, Hoefsloot LH, Schelen AM, Broeders LCAM, Meijer Y, et al. 1994. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc. Natl. Acad. Sci. USA 91:4480-84
50. Doshi PD, DiPersio JF. 1994. Three conserved motifs in the extracellular domain of the human granulocyte-macrophage colony-stimulating factor receptor subunit are essential for ligand binding and surface expression. Blood 84:2539-53
51. Drachman TG, Griffin JD, Kaushansky K. 1995. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl. J. Biol. Chem. 270:4979-82
52. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713-16
53. Duquesnoy P, Sobrier ML, Amselem S, Goossens M. 1991. Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome. Proc. Natl. Acad. Sci. USA 88:10272-76
54. Duquesnoy P, Sobrier ML, Duriez B, Dastot F, Buchanan CR, et al. 1994. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J. 13:1386-95
55. Duriez B, Sobrier ML, Duquesnoy P, Tixier-Boichard M, Decuypere E, et al. 1993. A naturally occurring growth hormone receptor mutation: in vivo and in vitro evidence for the functional importance of the WS motif common to all members of the cytokine receptor superfamily. Mol. Endocrinol. 7:806-14
56. Dusanter-Fourt I, Muller O, Ziemiecke A, Mayeux P, Drucker B, et al. 1994. Identification of jak protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimeras expressed in lymphoid cells. EMBO J. 13:2583-91
57. Elberg G, Kelly PA, Djiane J, Binder L, Gertler A. 1990. Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells. Selective enhancement by anti-mouse IgG. J. Biol. Chem. 265:14770-76
58. Elliot S, Lorenzini T, Yanagihara D, Elliot G, Chang D. 1995. Isolation and characterization of anti rHuEPO receptor monoclonal antibodies that activate the EPO receptor. Exp. Hematol. 23(8):828
59. Ernst M, Gearing DP, Dunn AR. 1994. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transduction subunit gp130 in embryonic stem cells. EMBO J. 13:1574-84
60. Escary JL, Perreau J, Dum'enil D, Ezine S, Brulet P. 1993. Leukaemia inhibitory factor is necessary for maintenance of hematopoietic stem cells and thymocyte stimulation. Nature 363:361-64
61. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM. 1993. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823-32
62. Ferro F Jr, Kozak SL, Hoatlin ME, Rabat D. 1993. Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J. Biol. Chem. 268:5741-47
63. Franks SJ, Yi W, Goldsmith JF, Gilliland G, Jiang J, et al. 1995. Regions of the jak2 tyrosine kinase required for coupling to the growth hormone receptor. J. Biol. Chem. 270:14776-85
64. Friend C. 1957. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J. Exp. Med. 105:307-18
65. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA. 1992. Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677-80
66. Fujii H, Nakagawa Y, Schindler U, Kawahara A, Mori H, et al. 1995. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal transmission. Proc. Natl. Acad. Sci. USA 92:5482-86
67. Fukunaga R, Ishizaka-Ikeda E, Nagata S. 1990a. Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J. Biol. Chem. 265:14008-15
68. Fukunaga R, Ishizaka-Ikeda E, Nagata S. 1993. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell 74:1079-87
69. Fukunaga R, Ishizaka-Ikeda E, Pan C-X, Seto Y, Nagata S. 1991. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 10:2855-65
70. Fukunaga R, Ishizaka-Ikeda E, Seto Y, Nagata S. 1990b. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 61:341-50
71. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, et al. 1992. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434-37
72. Gearing DP, King JA, Gough NM, Nicola NA. 1989. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J. 8:3667-76
73. Gearing DP, Thut CJ, VandenBos T, Gimpel SD, Delaney PB, et al. 1991. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 10:2839-48
74. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, et al. 1994. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822-30
75. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, et al. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 14:3654-63
76. Goodwin RG, Friend D, Ziegler SF, Jerzy R, Falk BA, et al. 1990. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 60:941-51
77. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, et al. 1994. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965-68
78. Greenlund AC, Farrar MA, Viviano BL, Schreiber RD. 1994. Ligand-induced IFNγ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13:1591-600
79. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. 1994. Thrombocytopenia in c-mpl-deficient mice. Science 265:1445-47
80. Gurney AL, Wong SC, Henzel WJ, de Sauvage FJ. 1995. Distinct regions of c-mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation. Proc. Natl. Acad. Sci. USA 92:5292-96
81. Hackett RH, Wang YD, Larner AC. 1995. Mapping of the cytoplasmic domain of the human growth hormone receptor required for the activation of Jak2 and Stat proteins. J. Biol. Chem. 270:21326-30
82. Hankins WD, Troxler D. 1980. Polycythemia-and anemia-inducing erythroleukemia viruses exhibit differential erythroid transforming effects in vitro. Cell 22:693-99
83. Hara T, Miyajima A. 1992. Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3). EMBO J. 11:1875-84
84. Harrison DA, Binar R, Stines T, Gilman M, Perrimon N. 1995. Activation of a Drosophila Janus kinase (JAK) causes hematopoielic neoplasia and developmental defects. EMBO J. 14:2857-65
85. Hatakeyama M, Kono T, Kobayashi N, Kawahara A, Levin SD, et al. 1991. Interaction of the IL-2 receptor with the src-family kinase p561ck: identification of novel intermolecular association. Science 252:1523-28
86. Hatakeyama M, Mori H, Doi T, Taniguchi T. 1989a. A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 59:837-45
87. Hatakeyama M, Tsudo M, Minamoto S, Kono T, Doi T, et al. 1989b. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cD-NAs. Science 244:551-56
88. Hayashida K, Kitamura T, Gorman DM, Aral K-I, Yokota T, Miyajima A. 1990. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc. Natl. Acad. Sci. USA 87:9655-59
89. He TC, Jiang N, Zhuang H, Wojchowski DM. 1995. Erythropoietin recruitment of she via a receptor phosphotyrosine-independent, Jak2-associated pathway. J. Biol. Chem. 270:11055-61
90. Heim MH, Kerr IM, Stark GR, Darnell JE. 1995. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267:1347-49
91. Heldin C-H. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80:213-23
92. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63:1149-57
93. Hilton DJ, Hilton AA, Raicevic A, Raker S, Harrison-Smith M, et al. 1994. Cloning of a murine IL-11 receptor α-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 13:4765-75
94. Hilton DJ, Watowich SS, Katz L, Lodish HF. 1996a. Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor. J. Biol. Chem. 271:4699-4708
95. Hilton DJ, Watowich SS, Murray PJ, Lodish HF. 1995. Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. Proc. Natl. Acad. Sci. USA 92:190-94
96. Hilton DJ, Zhang J-G, Metcalf D, Alexander WS, Nicola NA, Willson TA. 1996b. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93:497-501
97. Hirota H, Yoshida K, Kishimoto T, Taga T. 1995. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. USA 92:4862-66
98. Hoatlin ME, Kozak SL, Lilly F, Chakraborti A, Kozak CA, Kabat D. 1990. Activation of the erythropoietin receptor by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Proc. Natl. Acad. Sci. USA 87:9985-89
99. Hooper KP, Padmanabhan R, Ebner KE. 1993. Expression of the extracellular domain of the rat liver prolactin receptor and its interaction with ovine prolactin. J. Biol. Chem. 268:22347-52
100. Horak ID, Gross RE, Lucas PJ, Horak EM, Waldmann TA, Bolen JB. 1991. T-lymphocyte interleukin-2 dependent tyrosine protein kinase signal transduction involves the activation of p561ck. Proc. Natl. Acad. Sci. USA 88:1996-2000
101. Hubbard SR, Wei L, Ellis L, Hendrickson WA. 1994. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372:746-54
102. Ihle JN. 1995. Cytokine receptor signalling. Nature 311:591-94
103. Improta T, Schindler C, Horvath CM, Kerr IM, Stark GR, Darnell JE. 1994. Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein. Proc. Natl. Acad. Sci. USA 91:4776-80
104. Ip NY, Nye SH, Boulton TG, Davis S, Taga T, et al. 1992. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69:1121-32
105. Ivashkiv LB. 1995. Cytokines and STATs: how can signals achieve specificity? Immunity 3:1-4
106. Johnston JA, Kawamura M, Kirken R, Chen Y, Blake TB, et al. 1994. Phosphorylation and activation of the jak2 Janus kinase in response to IL-2. Nature 370:151-53
107. Johnston JA, Wang L-M, Hanslon EP, Sun X-J, White MF, et al. 1995. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. J. Biol. Chem. 270:28527-30
108. Jucker M, Feldman RA. 1995. Identification of a new adapter protein that may link the common β subunit of the receptor for granulocyte/macrophage colony stimulating factor, interleukin-3 (IL-3), and IL-5 to phosphatidylinositol 3-kinase. J. Biol. Chem. 270:27817-22
109. Kabat D. 1989. Molecular biology of Friend viral erythroleukemia. Curr. Top. Microbiol. Immunol. 148:1-42
110. Karnitz LM, Burns LA, Sutor SL, Blenis J, Abrahams RT. 1995. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Mol. Cell. Biol. 15:3049-57
111. Kaushansky K. 1995. Thrombopoietin: the primary regulator of platelet production. Blood 86:419-31
112. Kaushansky K, Karplus PA. 1993. Hematopoietic growth factors: understanding functional diversity in structural terms. Blood 82:3229-40
113. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, et al. 1994. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369:568-71
114. Kawahara A, Minami Y, Ihle JN, Taniguchi T. 1995. Critical role of the interleukin 2 (IL-2) receptor γ-chain-associated Jak3 in the IL-2-induced c-fos and c-myc but not bcl-2 induction. Proc. Natl. Acad. Sci. USA 92:8724-28
115. Kawahara A, Minami Y, Taniguchi T. 1994. Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor γ chain in IL-2, IL-4, and IL-7 signaling. Mol. Cell. Biol. 14:5433-40
116. Kawase I, Brooks CG, Kuribayashi K, Olabuenaga S, Newman W, et al. 1983. Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. J. Immunol. 131:288-92
117. Keegan AD, Nelms K, White M, Wang L-M, Pierce JH, Paul WE. 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4 mediated IRS-1 phosphorylation and cell growth. Cell 76:811-20
118. Kishimoto T, Akira S, Narazaki M, Taga T. 1995. Interleukin-6 family of cytokines and gp130. Blood 86:1243-54
119. Kishimoto T, Taga T, Akira S. 1994. Cytokine signal transduction. Cell 76:253-62
120. Kitamura T, Hayashida K, Sakamaki K, Yokota T, Arai K-I, Miyajima A. 1991b. Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF): evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor. Proc. Natl. Acad. Sci. USA 88:5082-86
121. Kitamura T, Miyajima A. 1992. Functional reconstitution of the human interleukin-3 receptor. Blood 80:84-90
122. Kitamura T, Sato N, Arai K-I, Miyajima A. 1991a. Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 66:1165-74
123. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729-38
124. Kobayashi N, Kono T, Hatakeyama M, Minami Y, Miyazaki T, et al. 1993. Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin-2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction. Proc. Natl. Acad. Sci. USA 90:4201-5
125. Kondo M, Takeshita T, Higuchi M, Nakamura M, Sudo T, et al. 1994. Functional participation of the IL-2 receptor γ chain in IL-7 receptor complexes. Science 263:1453-54
126. Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, et al. 1993. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262:1874-77
127. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, et al. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-42
128. Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourne EA, et al. 1996. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15-24
129. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-48
130. Kopf M, Ramsay A, Brombacher F, Baumann H, Freer G, et al. 1995. Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses. Ann. NY Acad. Sci. 762:308-18
131. Krantz SB. 1991. Erythropoietin. Blood 77:419-34
132. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I. 1993. Immune responses in interleukin-2-deficient mice. Science 262:1059-61
133. Lane DP, Benchimol S. 1990. p53: oncogene or anti-oncogene? Genes Dev. 4:1-8
134. Laron Z. 1995. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. J. Clin. Endocrinol. Metab. 80:1526-31
135. Lebrun J-J, Ali S, Goffin V, Ullrich A, Kelly PA. 1995b. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc. Natl. Acad. Sci. USA 92:4031-35
136. Lebrun J-J, Ali S, Ullrich A, Kelly PA. 1995a. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J. Biol. Chem. 270:10664-70
137. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, et al. 1987. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537-43
138. Leung S, Qureshi SA, Kerr IM, Darnell JE, Stark GR. 1995. Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 15:1312-17
139. Levy DE, Kessler DS, Pine R, Darnell JE. 1989. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev. 3:1362-71
140. Levy DE, Kessler DS, Pine R, Reich N, Darnell JE. 1988. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev. 2:383-93
141. Lew DJ, Decker T, Strehlow I, Darnell JE. 1991. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol. Cell. Biol. 11:182-91
142. Li J-P, Baltimore D. 1991. Mechanism of leukemogenesis induced by mink cell focus-forming murine leukemia viruses. J. Virol. 65:2408-14
143. Li J-P, D'Andrea AD, Lodish HF, Baltimore D. 1990. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343:762-64
144. Li J-P, Hu HO, Niu QT, Fang C. 1995. Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55. J. Virol. 69:1714-19
145. Li M, Sendtner M, Smith A. 1995. Essential function of LIF receptor in motor neurons. Nature 378:724-27
146. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, et al. 1994. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:1737-46
147. Lin CS, Lim SK, D'Agati V, Costantini F. 1996. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev. 10:154-64
148. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, et al. 1994. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565-68
149. Tum-1 Jak kinase causes leukemia-like hematopoietic defects. EMBO J. 14:1412-20
150. Macchi P, Villa A, Gillani S, Sacco MG, Frattini A, et al. 1995. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 376:65-68
151. Malkovsky M, Loveland B, North M, Asherson GL, Gao L, et al. 1987. Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature 325:262-65
152. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H. 1993. Disruption of the CNTF gene results in motor neuron degeneration. Nature 365:27-32
153. Matsuda T, Fukada T, Takahashi-Tezuka M, Okuyama Y, Fujitani Y, et al. 1995a. Activation of fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J. Biol. Chem. 270:11037-39
154. Matusda T, Takahashi-Tezuka M, Fukada T, Okuyama Y, Fujitani Y, et al. 1995b. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 85:627-33
155. Meacham LR, Brown MR, Murphy TL, Keret R, Silbergeld A, et al. 1993. Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron's syndrome. J. Clin. Endocrinol. Metab. 77:1379-83
156. Mertelsmann R. 1993. Hematopoietic cytokines: from biology and pathophysiology to clinical application. Leukemia 7:S168-77
157. Metcalf D. 1984. The Hematopoietic Colony Stimulating Factors. Amsterdam/New York/Oxford: Elsevier
158. Metcalf D. 1989. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339:27-30
159. Metcalf D. 1993. Hematopoietic regulators: redundancy or subtlety? Blood 82:3515-23
160. Minami Y, Kono T, Yamada K, Kobayashi N, Kawahara A, et al. 1993. Association of p56lck with IL-2 receptor β chain is critical for the IL-2-induced activation of p56lck. EMBO J. 12:759-68
161. Minami Y, Nakagawa Y, Kawahara A, Miyazaki T, Sada K, et al. 1995. Protein tyrosine kinase syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity 2:89-100
162. Miura O, Cleveland JL, Ihle JN. 1993. Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Mol. Cell. Biol. 13:1788-95
163. Miyajima A, Hara T, Kitamura T. 1992. Common subunits of cytokine receptors and the functional redundancy of cytokines. Trends Biochem. Sci. 17:378-82
164. Miyajima A, Mui AL-F, Ogorochi T, Sakamaki K. 1993. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82:1960-74
165. Miyazaki T, Liu Z-J, Kawahara A, Minami Y, Yamada K, et al. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc and lck cooperate in hematopoietic cell proliferation. Cell 81:223-31
166. Moreau-Gachelin F, Ray D, de Both NJ, van der Feltz MJ, Tambourin P, Tavitian A. 1990. Spi-1 oncogene activation in Rauscher and Friend murine virus-induced acute erythroleukemias. Leukemia 4:20-23
167. Morrison SJ, Uchida N, Weissman IL. 1995. The biology of hematopoietic stem cells. Annu. Rev. Cell Dev. Biol. 11:35-71
168. Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, et al. 1989. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335-48
169. Muller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, et al. 1993. The protein tyrosine kinase Jakl complements defects in interferon-α/β and -yγ signal transduction. Nature 366:129-35
170. Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, et al. 1993. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260:1808-10
171. Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, et al. 1991. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. USA 88:11349-53
172. Narazaki M, Witthuhn BA, Yoshida K, Kishimoto T, Taga T. 1994. Activation of Jak2 kinase mediated by the IL-6 signal transducer, gp130. Proc. Natl. Acad. Sci. USA 91:2285-89
173. Nicola NA. 1989. Hemopoietic cell growth factors and their receptors. Annu. Rev. Biochem. 58:45-77
174. Nicolson SE, Oates AC, Harpur AG, Ziemiecke A, Wilks AF, Layton JE. 1994. Tyrosine kinase jak1 is associated with the granulocyte-colony stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc. Natl. Acad. Sci. USA 91:2985-88
175. Nikaido T, Shimizu A, Ishida N, Sabe H, Teshigawara K, et al. 1984. Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311:631-35
176. Nishinakamura R, Nakayama N, Hirabayashi Y, Inoue T, Aud D, et al. 1995. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity 2:211-22
177. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, et al. 1993a. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 262:1877-80
178. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, et al. 1993b. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147-57
179. Nosaka T, van Deursen JMA, Tripp RA, Thierfelder WE, Witthuhn BA, et al. 1995. Defective lymphoid development in mice lacking Jak3. Science 270:800-2
180. Ogawa M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844-53
181. Ohashi T, Masuda M, Ruscetti SK. 1995. Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood 85:1454-62
182. Pallard C, Gouilleux F, Benit L, Cocault L, Souyri M, et al. 1995. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J. 14:2847-56
183. Park SY, Saijo K, Takahashi T, Osawa M, Arase H, et al. 1995. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3:771-82
184. Pellegrini S, Schindler C. 1993. Early events in signaling by interferons. Trends Biochem. Sci. 18:338-42
185. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, et al. 1995. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. USA 92:112-46
186. Pepper AE, Buckley RH, Small TN, Puck JM. 1995. Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency. Am. J. Hum. Genet. 57:564-71
187. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1955-60
188. Pharr PN, Hankins D, Hofbauer A, Lodish HF, Longmore GD. 1993. Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burstforming unit, and granulocyte/macrophage progenitor growth. Proc. Natl. Acad. Sci. USA 90:938-42
189. Philo JS, Aoki KH, Arakawa T, Owers Narhi L, Wen J. 1996. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. Biochemistry. In press
190. Quelle FW, Thierfelder W, Witthuhn BA, Tang B, Cohen S, Ihle JN. 1995. Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor. J. Biol. Chem. 270:20775-80
191. Rao MS, Sun Y, Escary JL, Perreau J, Tresser S. 1993. Leukaemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 11:1175-85
192. Rao P, Mufson RA. 1995. A membrane proximal domain of the human interleukin-3 receptor βc subunit that signals DNA synthesis in NIH 3T3 cells specifically binds a complex of src and janus family tyrosine kinases and phosphatidylinositol 3-kinase. J. Biol. Chem. 270:6886-93
193. Renauld J-C, Druez C, Kermouni A, Houssiau F, Uyttenhove C, et al. 1992. Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc. Natl. Acad. Sci. USA 89:5690-94
194. Ridderstrale M, Degerman E, Tornqvist H. 1995. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J. Biol. Chem. 270:3471-74
195. Ronco LV, Silverman SL, Wong SG, Slamon DJ, Park LS, Gasson JC. 1994. Identification of conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit critical for function. Evidence for formation of a heterodimeric receptor complex prior to ligand binding. J. Biol. Chem. 269:277-83
196. Rozakis-Adcock M, Kelly PA. 1991. Mutational analysis of the ligand-binding domain of the prolactin receptor. J. Biol. Chem. 266:16472-77
197. Rui H, Kirken RA, Farrar WL. 1994. Activation of receptor-associated tyrosine kinase Jak2 by prolactin. J. Biol. Chem. 269:5364-68
198. Ruscetti SK, Janesch NJ, Chakraborti A, Sawyer ST, Hankins WD. 1990. Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line. J. Virol. 64:1057-64
199. Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, et al. 1994. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266:1042-45
200. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, et al. 1993. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 262:1880-83
201. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, et al. 1995. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270: 797-800
202. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253-61
203. Sakai I, Nabell L, Kraft AS. 1995. Signal transduction by a CD16/CD7/Jak2 fusion protein. J. Biol. Chem. 270:18420-27
204. Sakamaki K, Miyajima I, Kitamura T, Miyajima A. 1992. Critical cytoplasmic domains of the common β subunit of the human GM-CSF, IL-3, and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J. 11:3541-49
205. Satoh T, Minami T, Kono T, Yamada K, Kawahara A, et al. 1992. Interleukin 2-induced activation of ras requires two domains of interleukin 2 receptor β subunit, the essential region for growth stimulation and lck-binding domain. J. Biol. Chem. 267:25423-27
206. Sattler M, Durstin MA, Frank DA, Okuda K, Kaushansky K, et al. 1995. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp. Hematol. 23:1040-48
207. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621-24
208. Showers MO, De Martino JC, Saito Y, D'Andrea AD. 1993. Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line. Mol. Cell. Biol. 13:739-48
209. Showers MO, Moreau JF, Linnekin D, Druker B, D'Andrea AD. 1992. Activation of the erythropoietin receptor by the Friend spleen focus-forming virus gp55 glycoprotein induces constitutive protein tyrosine phosphorylation. Blood 80:3070-78
210. Shuai K, Horvath CM, Huang LHT, Qureshi SA, Cowburn D, Darnell JE. 1994. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76:821-28
211. Shuai K, Schindler C, Prezioso VR, Darnell JE. 1992. Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258:1808-12
212. Sidman CL, Marshall JD, Shultz LD, Gray PW, Johnson HM. 1984. Gamma-interferon is one of several direct B cell-maturing lymphokines. Nature 309:801-4
213. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN. 1993. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc. Natl. Acad. Sci. USA 90:8429-33
214. Skoda RC, Seldin DC, Chiang MK, Peichel CL, Vogt TF, Leder P. 1993. Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J. 12:2645-53
215. Smith KA. 1988. Interleukin 2: inception, impact, and implications. Science 240:1169-76
216. Sokol L, Luhovy M, Guan Y, Prchal J, Semenza G, Prchal J. 1995. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 86:15-22
217. Sokol L, Prchal JF, D'Andrea AD, Rado TA, Prchal JT. 1994. Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia. Exp. Hematol. 22:447-53
218. Somers W, Ultsch M, De Vos AM, Kossiakoff AA. 1994. The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372:478-81
219. Souyri M, Vigon I, Penciolelli JF, Heard JM, Tambourin P, Wendling F. 1990. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 63:1137-47
220. Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, et al. 1994. Association and activation of Jak-Tyk kinases by CNTF-LIF-OM-IL-6 β receptor components. Science 263:92-95
221. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JE, Yancopoulos GD. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349-53
222. Stahl N, Yancopoulos GD. 1993. The alphas, betas, and kinases of cytokine receptor complexes. Cell 74:587-90
223. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, et al. 1994. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91:5592-96
224. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, et al. 1992. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359:76-79
225. Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268:1472-76
226. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, et al. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573-81
227. Takaki S, Mita S, Kitamura T, Yonehara S, Yamaguchi N, et al. 1991. Identification of the second subunit of the murine interleukin-5 receptor: interleukin-3 receptor-like protein, AIC2B is a component of the high affinity interleukin-5 receptor. EMBO J. 10:2833-38
228. Takaki S, Murata Y, Kitamura T, Miyajima A, Tominaga A, Takatsu K. 1993. Reconstitution of the functional receptors for murine and human interleukin-5. J. Exp. Med. 177:1523-29
229. Takaki S, Tominaga A, Hitoshi Y, Mita S, Sonada E, et al. 1990. Molecular cloning and expression of the murine interleukin-5 receptor. EMBO J. 9:4367-74
230. Taniguchi T, Minami Y. 1993. The IL-2/IL-2 receptor system: a current overview. Cell 73:5-8
231. Tanner JW, Chen W, Young RL, Longmore GD, Shaw AS. 1995.The conserved Box1 motif of cytokine receptors is required for association with Jak kinases. J. Biol. Chem. 270:6523-30
232. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, et al. 1995. Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-71
233. Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, et al. 1991. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66:1175-84
234. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ. 1995. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270:794-97
235. Torigo T, Saragovi HU, Reed JC. 1992. Interleukin-2 regulates the activity of the lyn protein tyrosine kinase in a B-cell line. Proc. Natl. Acad. Sci. USA 89:2674-78
236. Truitt KE, Mills GB, Turck CW, Imboden JB. 1994. SH2-dependent association of phosphatidylinositol 3-kinase 85-kDa regulatory subunit with the interleukin-2 receptor beta chain. J. Biol. Chem. 269:5937-43
237. Vajdy M, Kosco-Vilbois MH, Kopf M, Kohler G, Lycke N. 1995. Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181:41-53
238. v). Exp. Hematol. 17:81-87
239. Vaux DL, Cory S, Adam JM. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-42
240. Velazquez L, Fellous M, Stark GR, Pellegrini S. 1992. A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70:313-22
241. Vigon I, Mornon J-P, Cocault L, Mitjavila M-T, Tambourin P, et al. 1992. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc. Natl. Acad. Sci. USA 89:5640-44
242. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. 7. Exp. Med. 181:1519-26
243. Wakao H, Gouilleux F, Groner B. 1994. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 13:2182-91
244. Walter MR, Windsor WT, Nagabhushan TL, Lundell DJ, Lunn CA, et al. 1995. Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor. Nature 376:230-35
245. Wang L-M, Myers MG Jr, Sun X-J, Aaronson WA, White MF, Pierce JH. 1993. IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 261:1591-94
246. Ward LD, Hewlett GJ, Discolo G, Yasukawa K, Hammacher A, et al. 1994. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp130. 7. Biol. Chem. 269:23286-89
247. Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D. 1995. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121:1283-99
248. Watling D, Guschin D, Muller M, Silvennoinen O, Witthuhn BA, et al. 1993. Complementation of a mutant cell line defective in the interferon-γ signal transduction pathway. Nature 366:166-70
249. Watowich SS, Hilton DJ, Lodish HF. 1994. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell. Biol. 14:3535-49
250. Watowich SS, Yoshimura A, Longmore GD, Hilton DJ, Yoshimura Y, Lodish HF. 1992. Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl Acad. Sci. USA 89:2140-44
251. Wegenka UM, Lutticken C, Buschmann J, Yuan J, Lottspeich F, et al. 1994. The interleukin-6-activated acute-phase response factor is anti-genically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol Cell. Biol. 14:3186-96
252. Weiss M, Yokoyama C, Shikama Y, Naugle C, Druker B, Sieff CA. 1993. Human granulocyte-macrophage colony-stimulating factor receptor signal transduction requires the proximal cytoplasmic domains of the a and β subunits. Blood 82:3298-306
253. Welte T, Garimorth K, Philipp S, Doppler W. 1994. Prolactin-dependent activation of a tyrosine phosphorylated DNA binding factor in mouse mammary epithelial cells. Mol. Endocrinol. 8:1091-102
254. Wen Z, Zhong Z, Darnell JE. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-50
255. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, et al. 1994. cMp1 ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571-74
256. Wendling F, Varlet P, Charon M, Tambourin P. 1986. MPLV: aretrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology 149:242-46
257. White MF. 1994. The IRS-1 signaling system. Curr. Opin. Genet. Dev. 4:47-54
258. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. 1995. Interleukin-2 receptor or chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521-30
259. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR. 1990. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76-79
260. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, et al. 1993. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-36
261. Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, et al. 1994. Involvement of the jak3 Janus kinase in IL-2 and 1L-4 signaling in lymphoid and myeloid cells. Nature 370:153-57
262. Wolff L, Ruscetti S. 1985. Malignant transformation of erythroid cells in vivo by introduction of a nonreplicating retrovirus vector. Science 228:1549-52
263. Wu H, Klingmuller U, Besmer P, Lodish HF. 1995a. Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377:242-46
264. Wu H, Liu X, Jaenisch R, Lodish HF. 1995b. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59-67
265. Yamamura Y, Noda M, Ikawa Y. 1994. Activated Ki-Ras complements erythropoietin signaling in CTLL-2 cells, inducing tyrosine phosphorylation of a 160-kDa protein. Proc. Natl. Acad. Sci. USA 91:8866-70
266. Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, et al. 1988. Cloning and expression of the human interleukin-6 (BSF-2/IFNβ 2) receptor. Science 241:825-28
267. Yi T, Mui AL-F, Krystal G, Ihle JN. 1993. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor β chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol. Cell. Biol. 13:7577-86
268. Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, et al. 1996. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 93:407-11
269. Yoshida Y. 1994. Overview of the hematopoietic growth factors and cytokines - past, present and future. Int. J. Hematol. 60:177-83
270. Yoshimura A, D' Andrea AD, Lodish HF. 1990b. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc. Natl. Acad. Sci. USA 87:4139-43
271. Yoshimura A, Longmore G, Lodish HF. 1990a. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 348:647-49
272. Yoshimura A, Zimmers T, Neumann D, Longmore G, Yoshimura Y, Lodish HF. 1992. Mutations in the WSXWS motif of the erythropoietin receptor abolish processing, ligand-binding, and activation of the receptor. J. Biol. Chem. 267:11619-25
273. Zhang X, Blenis J, Li H-C, Schindler C, Chen-Kiang S. 1995. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267:1990-94
274. c chain. J. Biol. Chem. 270:13814-18
275. Zhuang H, Patil SV, He T-C, Sonsteby SK, Niu Z, Wojchowski DM. 1994. Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J. Biol. Chem. 269:21411-14
276. Ziegler SF, Bird TA, Morella KK, Mosley B, Gearing DP, Baumann H. 1993. Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction. Mol. Cell Biol. 13:2384-90
277. Ziemiecki A, Harpur AG, Wilks AF. 1994. Jak protein tyrosine kinases: their role in cytokine signaling. Trends Cell Biol. 4:207-12
278. Zon LI, Moreau JF, Koo JW, Mathey-Prevot B, D'Andrea AD. 1992. The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein. Mol. Cell. Biol. 12:2949-57
279. Zurawski SM, Chormarat P, Djossou O, Bidaud C, McKenzie ANJ, et al. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 270:13869-78
280. Zurawski SM, Vega F, Huyghe B, Zurawski G. 1993. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12:2663-70